Pharmaceuticals, Biotechnology and Life Sciences
Appointments of new CEO, CFO, and seasoned business development leaders with proven track records of executing strategic transactions will position…
WESTLAKE VILLAGE, Calif., July 23, 2025 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing…
Idorsia will publish its Half Year 2025 Financial Reporting on Wednesday July 30, at 07:00 CEST. An investor webcast and…
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) — With consumers increasingly turning to natural wellness products, THCa flower has become…
BERWYN, Pa., July 23, 2025 (GLOBE NEWSWIRE) — AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical…
New Iso-Seq data from ~1,000 samples to expand transcriptomic insights using highly accurate HiFi sequencingMENLO PARK, Calif., July 23, 2025…
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) — Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs),…
BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”)…
Vancouver, Canada, July 23, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a…
ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) — Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral…